GH
PACB icon

GAM Holding’s Pacific Biosciences PACB Stock Holding History

GAM Holding’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,659
Closed -$464K – 323
2021
Q4 		$464K Sell
22,659
-7,011
-24% -$169K 0.02% 241
2021
Q3 		$758K Hold
29,670
– – 0.04% 214
2021
Q2 		$1.04M Buy
+29,670
New +$863K 0.05% 222
2019
Q2 		– Sell
-126,500
Closed -$915K – 916
2019
Q1 		$915K Sell
126,500
-46,000
-27% -$333K 0.04% 455
2018
Q4 		$1.28M Buy
+172,500
New +$1.09M 0.06% 305

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return